Workshop Workshop B track
Doctor-to-Doctor: A PI-Led Pathway into Japan Using AI, DCT, and Registration-Directed Investigator-Initiated Trials to Reach Japanese Patients Faster
Mon, Nov 9, 2026 · 9:00–10:00 AM CET Biomanufacturing Strategy Stage, Koelnmesse
About this session
Interactive Workshop For most global biotechs, the hardest part of entering Japan is not regulation — it is finding the right clinical leader. Sponsors typically begin by selecting a CRO, but the decisive first move is identifying the Japanese Principal Investigator best suited to the asset: the physician who understands the disease, can reach the target patients, and is willing to lead a registration-directed program. This workshop presents a PI-led alternative to the traditional sponsor-and-CRO model.
